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Abstract
Background: Template switching between two distinct HIV-1 RNA genomes during reverse transcription gives rise
to recombinant viruses that greatly expand the genetic diversity of HIV-1 and have adverse implications for drug
resistance, immune escape, and vaccine design. Virions with two distinct genomes are produced exclusively from
cells infected with two or more viruses, or ‘doubly infected’ cells. Previous studies have revealed higher than
expected frequencies of doubly infected cells compared to frequencies based on chance alone, suggesting
non-random enhancement of double infection.
Methods: We investigated double infection of unstimulated primary CD4+ T cells using reporter viruses carrying
genes for different fluorescent proteins, EGFP and mCherry, combined with sophisticated modeling techniques
based on Poisson distribution. Additionally, through the use of multiparameter flow cytometry we examined the
susceptibility of naïve and memory subsets of CD4+ T cells to double infection by HIV.
Results: Using our double infection system, we confirm non-random enhancement of multiple infection events.
Double infection of CD4+ T cells was not found to be a consequence of suboptimal provirus expression rescued
by Tat in trans—as has been reported in cell lines—but rather due to a heterogeneous cell population in which
only a fraction of primary peripheral blood CD4+ T cells are susceptible to HIV infection regardless of viral titer.
Intriguingly, double infection of CD4+ T cells occurred preferentially in memory CD4+ T cells—particularly the
central memory (TCM) subset—but was not a consequence of SAMHD1-mediated restriction of HIV infection in
naïve cells.
Conclusions: These findings reveal that double infection in primary CD4+ T cells is primarily a consequences of
cellular heterogeneity and not rescue of suboptimal provirus expression by Tat in trans. Additionally, we report a
previously unappreciated phenomenon of enhanced double infection within primary TCM cells and suggest that
these long-lived cells may serve as an archive that drive ongoing viral recombination events in vivo.
HIV-1 has been transmitted from non-human primates
to humans on at least four separate occasions, giving rise
to HIV-1 groups M, N, O, and P [1–4]. HIV-1 group M,
which accounts for the vast majority of infections world-
wide, is believed to have been transmitted from chim-
panzees to humans in the early 20th century [5, 6].
SIVcpz, the simian immunodeficiency virus infecting
chimpanzees and the precursor of HIV-1, is the result of
recombination between primate immunodeficiency
viruses from red-capped mangabeys (SIVrcm) and
greater spot-nosed monkeys (SIVgsn) [7]. Following
transmission to humans, HIV-1 group M subsequently
diversified into phylogenetically distinct subtypes labeled
A1, A2, B, C, D, F1, F2, G, H, J and K. In addition, more
than 70 circulating recombinant forms (CRFs) have been
identified ([8] and the Los Alamos National Laboratory
HIV sequence database (http://www.hiv.lanl.gov/con-
tent/sequence/HIV/CRFs/CRFs.html)).
The role of recombination in the HIV-1 epidemic is
not purely historical but rather continues to contribute
to the remarkable genetic heterogeneity of viral se-
quences both within infected individuals as well as on a
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population level. In infected individuals, recombination
helps drive the rapid evolution of a diverse and com-
plex viral population from a small number of initial
founder viruses [9] and has adverse implications for
drug resistance and immune escape [10, 11]. On an
epidemiological scale, the genetic diversity of HIV-1
variants presents a significant challenge to vaccine
design [11].
Molecularly, recombination occurs as the viral reverse
transcriptase switches between two co-packaged gen-
omic RNAs. The diversity engendered by recombination
has been estimated to be on a similar frequency as the
nucleotide substitution rate in patients, with an average
of 1.4×10−5 recombinations per site per cycle [12]. Vi-
ruses produced from a cell infected by a single HIV vari-
ant have essentially identical viral genomes due to the
low error rate of host RNA polymerase II. Therefore,
while recombination can contribute to mutagenesis and
may account for 15–20 % of all mutations occurring
during reverse transcription [13], recombination can
occur in viruses from a singly infected cell but does not
lead to substantial reshuffling of viral genomes. A differ-
ent situation arises in cells that are infected by two dis-
tinct HIV viruses: here, viruses co-package potentially
diverse RNA genomes and recombination during subse-
quent infection of host cells can produce chimeric vi-
ruses. Thus, a pre-requisite for recombination events
leading to significant reshuffling of viral genomes is the
infection of host cells with two or more genetically dis-
tinct viruses, or ‘double infection’ of host cells [14].
In this study we investigated double infection of pri-
mary CD4+ T cells using reporter viruses expressing two
distinct fluorescent proteins, EGFP and mCherry. We
confirm previous reports that double infection of host
cells occurs more frequently than would be expected by
chance alone [15–17]. This non-random enhancement
of double infection has been proposed to be the result of
cellular heterogeneity [17] or rescue of suboptimal pro-
viral expression by Tat in trans [15]; however, this latter
mechanism did not account for enhanced double infec-
tion rates in primary CD4+ T cells using our combin-
ation reporter virus system. Instead, we observed that
the majority of CD4+ T cells in the peripheral blood are
refractory to HIV infection regardless of titer and that sin-
gle and double infection are restricted to a small popula-
tion of cells. Interestingly, double infection occurred
preferentially in central memory CD4+ T cells compared
to naïve CD4+ T cells. This phenomenon, which was inde-
pendent of enhanced SAMHD1-mediated restriction of
HIV in naïve CD4+ Tcells, suggests that long-lived central
memory CD4+ T cells are preferential targets for double
infection and may represent an archived population that is
an ongoing source of virions carrying distinct RNA ge-
nomes and driving recombination in vivo.
Methods
Cells
This study was conducted according to the principles
specified in the Declaration of Helsinki and under local
ethical guidelines (Case Western Reserve University In-
stitutional Review Board (IRB)). Normal donor samples
were de-identified and obtained from leukapheresis from
ALLCELLS, LLC. All donors were negative for HBV,
HCV, and HIV. A 10 year-old male with the homozy-
gous mutation c.1411-2A > G in the samhd1 gene, as re-
ported previously [18], was recruited from the DDC
Clinic (Middlefield, OH) with informed consent. The pa-
tient was on low-dose steroid (5 mg prednisone) treating
the underlying condition while the samples were ob-
tained. CD4+ T cells were isolated by adding additional
autologous red blood cells to leukapheresis samples and
RosetteSep CD4+ T cell enrichment kit antibodies
(STEMCELL Technologies) prior to ficoll gradient separ-
ation. Cells were cryopreserved and treated with benzo-
nase upon thawing, prior to infection. CD4+ T cells
from the patient with confirmed samhd1 mutations were
purified by negative selection from freshly isolated
PBMCs using a CD4+ T cell enrichment kit (STEM-
CELL Technologies).
Production of viruses
Combination reporter viruses were produced as previ-
ously described [19]. Briefly, HEK 293T cells were seeded
in 10 cm dishes and cultured overnight prior to transfec-
tion with 10.0 μg pNL4-3-deltaE-EGFP (obtained
through the NIH AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH: pNL4-3-
deltaE-EGFP (Cat #11100) from Drs. Haili Zhang, Yan
Zhou, and Robert Siliciano), 7.5 μg bla-Vpr plasmid (ob-
tained from Dr. Robert Doms), and 6.0 μg of HIV Env
(CXCR4-tropic HIV Envs: JOTO.TA1.2247 [20] (ob-
tained from Drs. Beatrice Hahn and George Shaw), IIIB/
LAI, and TYBE; CCR5-tropic HIV Envs: REJO.D12.1972
[21](Obtained from Drs. Hahn and Shaw), ADA, and JR-
CSF) using calcium phosphate methods [22]. Using the
same protocol, viruses used in co-infection experi-
ments were made using 10.0 μg of either pNL4-3-
deltaE-EGFP or 10.0 μg pNL4-3- deltaE-mCherry
(produced by replacing the egfp gene in the pNL4-3-
deltaE-EGFP plasmid with mCherry) and 6.0 μg of
CXCR4-tropic HIV Env JOTO.TA1.2247. Virus was
harvested 72 h after transfection, filtered, and concen-
trated by ultracentrifugation through a 20 % sucrose
cushion according to published protocols [23]. A p24
ELISA (Cell Biolabs, Inc.) was done with all viral stocks to
determine viral concentrations. Empirical titers were also
determined by infecting primary CD4+ T cells and evalu-
ating viral fusion (for bla-Vpr containing viruses) or
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reporter gene positivity (for viruses lacking the bla-Vpr
plasmid).
Infection experiments
For titration experiments, infections were set up in par-
allel plates. One plate was used to measure viral fusion
24 h post-infection, while the other plate was used to
measure productive infection 72 h post-infection. A
range of 1 to 2048 ng of p24-equivalent viral stock was
added to 5 × 105 cells per well of a 96-well V-bottom
plate. Cells were plated in RPMI media with 10 % FBS
and 1 % L-glutamine, spinoculated at 1200 × g at 25 °C
for 2 h and incubated at 37 °C for 1 h. No exogenous
stimuli, such as mitogens, CD3/CD28, or IL-2, were
added. The productive infection plate was transferred to
corresponding wells of a 96-well flat bottom plate and
incubated at 37 °C for staining at 72 h post-infection.
Cells in the fusion plate were washed with CO2-inde-
pendent media (Gibco) and incubated with CCF2-AM
dye (Invitrogen) for 1 h at room temperature according
to manufacturer instructions. Cells were then washed and
incubated in CO2-independent media containing 5 % hu-
man serum (Gemini Bio-Products) and 2.5 mM probene-
cid (Sigma Aldrich) overnight at room temperature for
staining 24 h post-infection. For co-infection experi-
ments, 125 or 250 ng p24-equivalents of viral stocks
were added to 106 primary unstimulated CD4+ T cells
in wells of a 96-well V-bottom plate. Cells were spino-
culated at 1200 × g at 25 °C for 2 h, incubated at 37 °C
for 1 h, and subsequently transferred to corresponding
wells of a 96-well flat bottom plate. Cells were incu-
bated for 72 h at 37 °C prior to staining for flow cytom-
etry. Infection conditions were assayed in duplicate. For
deoxynucleoside treatment of cells, 2’-deoxyadenosine,
2’deoxyguanosine, thymidine, and 2’deoxycytidine
hydrochloride were purchased from Sigma Aldrich.
Deoxynucleosides were dissolved in RPMI containing
10 % FBS and 1 % penicillin/streptomycin. Cells were
incubated in 1 mM dNs for 1 h at 37 °C prior to spino-
culation as described above.
Flow cytometry
For titration experiments, cells were stained with anti-
human CCR7 IgM (BD Biosciences) and fixable yellow
dead cell stain (Invitrogen) at 37 °C for 30 min, washed,
and incubated with anti-human CD3 BV650 (Biolegend),
CD4 APC (eBioscience), CD45RO ECD (Beckman
Coulter), and anti-IgM PE (Invitrogen) at 4 °C for
30 min. For coinfection experiments, cells were stained
with anti-human CCR7 IgM (Becton Dickinson) and fix-
able yellow dead cell stain (Invitrogen) at 37 °C for
30 min, washed, and incubated with anti-human CD3
BV650 (Biolegend), CD4 APC (eBioscience), CD45RA
APC-Cy7 (Biolegend), and anti-IgM PE (Invitrogen) at
4 °C for 30 min. Upon completion of antibody incuba-
tions, cells were washed with PBS and resuspended in
1 % paraformaldehyde in PBS/BSA prior to analysis
using a BD LSRII flow cytometer. At least 50,000 events
were collected per sample. FlowJo version 9.6 (Tree Star,
Inc.) was used for analysis.
Statistics
Unless otherwise specified, data in figures represent mean
values and standard error of the mean. All p values were
corrected for multiple comparisons where appropriate.
Statistical analyses were performed using the paired T-test
using GraphPad Prism v6.0e.
Results
We have recently developed an HIV-1 combination re-
porter virus system that monitors both fusion and LTR-
driven EGFP expression–a surrogate of production
infection–in the viral life cycle and provides insight into
the efficiency and outcome of infection [19]. Briefly,
combination reporter viruses are produced by co-
transfecting a packaging cell line with an NL4-3 core
containing an egfp gene in the place of env gp120, a plas-
mid encoding a β-lactamase–vpr (bla-vpr) fusion gene,
and a plasmid expressing an envelope gene, typically R5-
or X4-tropic HIV env. The resultant virions contain bla-
Vpr protein, which cleaves the β-lactamase substrate
CCF2-AM in cells following fusion, eliminating a fluor-
escent resonance energy transfer (FRET) linkage and al-
tering the fluorescent characteristics of the cell. If the
virions successfully complete reverse transcription, nu-
clear import, integration, and viral long terminal repeat
(LTR)-driven transcription, EGFP is produced in the
cells and can be detected by flow cytometry.
Using this system, we performed titrations of combin-
ation reporter viruses bearing CCR5- or CXCR4-tropic
HIV envelopes (Fig. 1a). The three combination reporter
viruses bearing CCR5-tropic viruses showed similar
maximal levels of fusion (~15 % of peripheral blood
CD4+ T cells), consistent with our previous findings
[19]. In contrast, combination reporter viruses bearing
CXCR4-tropic HIV Envs fused with 90–95 % of CD4+ T
cells. EGFP expression levels were also higher for
CXCR4-tropic HIV compared with CCR5-tropic HIV
(7.61 ± 2.69 % EGFP+ v. 1.21 ± 0.28 %).
To gain further insight into the stoichiometry of
HIV-1 infection using this system, we performed add-
itional experiments monitoring both viral fusion and
LTR-driven EGFP expression over a wider input range
of reporter virus with the goal of determining the num-
ber of viruses required to produce a detectable cleaved
CCF2-AM or EGFP signal in infected cells. A CXCR4-
tropic HIV Env was chosen for these studies to facili-
tate study of HIV infection of both naïve and memory
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Fig. 1 a Titration of combination reporter viruses bearing the CXCR4-tropic HIV Envs JOTO.TA1.2248, IIIB/LAI, or TYBE or the CCR5-tropic Envs
REJO.D12.1972, JRCSF, or ADA. Flow cytometry was used to measure the percentage of fusion(+) CD4+ T cells by detection of CCF2-AM dye
cleavage and EGFP(+) cells by the combination of EGFP expression and Nef-mediated CD4 downregulation. Closed and open symbols represent
data from separate normal donors. b Equation for Poisson distribution to predict the percentage of cells (P(n)) infected with n viruses. m is the
multiplicity of infection (MOI) and e is Euler’s number. The example shows the expected frequency of cells infected by 0, 1, 2, 3, 4, or 5 cells at
a MOI of 1. c Representative experiment (1 of 3) showing the percentage of unstimulated CD4+ T cells undergoing fusion (left) or expressing
EGFP (right) following infection with 1–2048 ng p24 equivalents of combination reporter viruses pseudotyped with the primary X4-tropic isolate
JOTO.TA1.2247. These experimental data are compared with data predicted by Poisson distribution if a threshold (x) number of 1, 2, or 3 viruses is
required for signal detection. Thresholds greater than x = 3 have increasingly steep slopes that do not match the experimental data. Multiplicity
of infection (MOI) values were calculated by determining the MOI that best fit the experimental data using the Poisson distribution formula. MOI
varied depending on the readout (fusion or EGFP signal) and whether the cells were spinoculated or not despite a constant number of cells
and identical viral titrations. (Note: titrations <16 ng p24 equivalents were not included for EGFP in the absence of spinoculation because these
concentrations did not result in signals above the background fluorescence of 0.02–0.03 % in the EGFP channel)
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cells and because the extended range of fusion and
EGFP values facilitated accurate modeling analysis. The
probability of a cell being infected by n viruses [P(n)]
can be determined using the Poisson distribution equa-
tion P nð Þ ¼ mn ∙e−mn! where m is the multiplicity of infec-
tion (MOI), and e is Euler’s number (Fig. 1b). Although
multiple infection events in a given cell cannot be dis-
tinguished using this assay, cells can be identified as ei-
ther uninfected or infected. If a single virus is sufficient
to provide a cleaved CCF2 or EGFP signal, only cells
with no virus [P(0)] will be detected as uninfected while
cells with one or more viruses [P(1) + P(2) + P(3)…] will
be detected as infected cells. In contrast, if a threshold
(x) number of viruses are required to generate a signal,
all cells infected with less than the threshold [P(0) +…
+ P(x-1)] will be counted as ‘uninfected’ while those at
the threshold or above [P(x) + P(x + 1) +…] will be de-
tected as ‘infected’. The practical consequence of this
observation is that as viral MOI is lowered, ‘infected’
cells decrease at characteristic rates depending how
many viruses are required for a signal to be generated.
We performed titration experiments using 2-fold in-
creases of HIV X4-tropic combination reporter viruses
from 1 to 2048 ng p24 equivalents. These data were
compared to decay curves calculated by Poisson distri-
bution at thresholds of 1, 2, and 3 viruses (x = 1, 2, and
3, respectively) required to generate fusion or LTR-
driven EGFP signals (Fig. 1c). The experimental data
tracked with the decay curves with a threshold of 1, in-
dicating that a single virus was sufficient to detect
CCF2 cleavage and EGFP signals. Two deviations from
the theoretical data were noted for EGFP signal. The
deviation at low viral input is due to background fluor-
escence in the EGFP channel of approximately 0.02–
0.03 % of CD4+ T cells and is observed even in unin-
fected samples. For this reason, viral inputs <16 ng p24
equivalents are not included in the EGFP “no spinocu-
lation” experiments because only background signal is
detectable. The second deviation at high viral input in
the presence of spinoculation is not a technical limita-
tion but rather reflects the finding that only a propor-
tion of unstimulated peripheral blood CD4+ T cells are
capable of being productively infected regardless of
viral titer, as will be discussed further.
Cells infected by more than one virus occur at higher
than expected frequencies
Several studies have previously reported that cells in-
fected by more than one virus occur at a higher than ex-
pected frequency in both primary cells and cell lines
[15–17]. To investigate this phenomenon, we infected
purified, unstimulated CD4+ T cells with viruses encod-
ing either egfp or mCherry reporter genes (Fig. 2a),
normalized by MOI. Cells expressing only EGFP or
mCherry were counted as singly infected cells and cells
expressing both EGFP and mCherry were counted as
doubly infected (representative experiment shown in
Fig. 2b). Using the observed frequency of singly infected
cells, we used the Poisson distribution to determine the
expected percentage of cells with two or more viruses
(Fig. 2c). As mentioned previously, we are unable to dis-
tinguish cells infected with one or multiple copies of the
same reporter gene, so these likely reflect slight overesti-
mates of the actual frequency of singly infected cells and
slight underestimates of doubly infected cells. Despite
this bias, and in agreement with previous studies, we
observed a statistically greater percentage of doubly in-
fected cells than predicted by Poisson distribution, indi-
cating nonrandom enhancement of double infection
(experimental: 1.88 ± 0.38 % double infected; expected:
0.35 ± 0.08 %, p = 0.002, Fig. 2d).
Higher than expected frequencies of double infection are
not due to suboptimal provirus expression rescued by
trans effects of Tat
Efficient expression of viral mRNAs from the HIV LTR
promoter requires the expression of viral Tat in cis to
recruit the elongation factor P-TEFb to the viral transac-
tivating region (TAR) element of nascent mRNAs, phos-
phorylate the C terminal domain of RNA Pol II, and
relieve the block to RNA elongation (recently reviewed
by Mbonye and Karn [24]). This Tat-mediated regulation
of the LTR promoter activity is a positive feedback loop:
Tat protein enhances viral mRNA production, leading to
higher Tat protein levels that in turn further enhance
promoter activity. In contrast, if Tat protein levels are in-
sufficient to recruit P-TEFb, HIV mRNAs stall at ~59 bp
in length and Tat levels are further diminished, a
phenomenon frequently referred to as suboptimal
provirus expression or direct silencing. One potential
explanation for the higher than expected frequencies
of doubly infected cells is that suboptimal provirus
expression could be rescued by Tat in trans, i.e. by
Tat produced by a second integrated provirus. Indeed,
Tat provided by a second virus can rescue reporter
gene expression from a Tat-defective virus in HeLa-
CD4 cells [15]. To evaluate whether suboptimal provirus
expression was also occurring in primary CD4+ T cells,
we performed experiments where cells from two healthy
controls were infected with a constant amount of EGFP-
expressing virus (40 ng p24 equivalents) and mCherry-
expressing viruses were added at increasing concentra-
tions from 0 to 512 ng p24 equivalents. We reasoned that
if suboptimal provirus expression was occurring and could
be rescued by Tat in trans, then the percentage of EGFP+
cells should increase with higher levels of mCherry viruses
as they activated silenced LTR promoters of egfp
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proviruses. However, while the slope of mCherry expres-
sion was significantly different than zero (p < 0.0001 for
both healthy controls), the slope of EGFP expression was
not (p > 0.50 for both, Fig. 3), indicating that mCherry vi-
ruses had no effect on the percentage of cells expressing
EGFP. These data demonstrate that Tat insufficiency and
rescue in trans is not responsible for the enhanced double
infection of primary CD4+ T cells.
Only a fraction of unstimulated CD4+ T cells in the
peripheral blood can become infected with HIV
An alternative explanation to the higher than expected
frequencies of double infection is that only a fraction of
cells are susceptible to HIV infection. If this hypothesis is
correct, single and double infection would be expected to
occur relatively frequently in the susceptible population
but rarely or not at all in non-susceptible cells. We empir-
ically tested this hypothesis in primary CD4+ T cells
through further titration experiments including extremely
high inputs of HIV reporter viruses. Cells from two nor-
mal donors were infected with combination reporter vi-
ruses at inputs between 1 and 2048 ng p24 equivalents.
Fusion of HIV with CD4+ T cells increased with viral in-
put until concentrations of 256 ng and above, at which
point a plateau was reached with 85–90 % of CD4+ T cells
fusing with HIV (Fig. 4a). Consistent with our previous
findings [19], the percentage of cells undergoing fusion
was ~10–20–fold higher than the percentage of cells
expressing LTR-driven EGFP. There are several potential
explanations for this phenomenon, including (a) a propor-
tion of viruses that are defective for producing EGFP, (b)









































































































Fig. 2 a Cells infected with viruses expressing EGFP, mCherry, or both can be distinguished by flow cytometry. Representative data (1 of 9) of
unstimulated primary CD4+ T cells infected with NL4-3-ΔE-EGFP and/or NL4-3-ΔE-mCherry reporter viruses pseudotyped with the primary X4-tropic
isolate JOTO.TA1.2247. b Frequencies of EGFP+/mCherry-, EGFP-/mCherry+, and EGFP+/mCherry + cells 72 h after infection of unstimulated CD4+ T
cells with EGFP and mCherry viruses, normalized by MOI. c For a given percentage of single positive cells (P(1), EGFP+mCherry- and EGFP-mCherry+),
the expected frequency of double positive cells (P(2)) can be predicted by Poisson distribution. d Comparison of actual frequencies of
double positive cells measured experimentally and frequences expected by Poisson distribution. The data are from experiments on 9
different healthy controls
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productive infection, or (c) both (Fig. 4b). Importantly, if
defective viral particles are solely responsible for the dif-
ference between fusion and EGFP signals, the percentage
of cells expressing EGFP should continue to increase over
the entire range of the input virus. In contrast, if only a
fraction of CD4+ T cells are susceptible to HIV, the per-
centage of cells expressing EGFP would be expected to
plateau once the susceptible population has been com-
pletely infected. The experimental data from both donors
clearly demonstrate a plateau of EGFP+ CD4+ T cells, in-
dicating that only a fraction of primary CD4+ T cells are
susceptible to HIV regardless of viral concentration. Al-
though CCR5 and CXCR4-tropic viruses differ markedly
in the percentage of cells that are susceptible to fusion
(Fig. 1a), the percentage of cells that progress to EGFP ex-
pression in both cases is only ~8 % of the total number of
fusion(+) cells (R5-tropic viruses: 8.99 ± 2.35 %, X4-tropic
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Fig. 3 Unstimulated CD4+ T cells were infected with a constant input of 40 ng of X4-pseudotyped EGFP virus and increasing concentrations of
X4-pseudotyped mCherry virus over a range from 0 to 512 ng. The slope of the total EGFP+ cells (EGFP+/mCherry- and EGFP+/mCherry+) was
not significantly different than 0 (p > 0.5 for both healthy controls). The slope of total mCherry + cells and doubly infected (EGFP +mCherry+)
cells were both significantly different than 0 (total mCherry + cells: p < 0.0001 for both controls; doubly infected cells: p = 0.0004 and p = 0.015,
respectively). Representative data from 2 (of 4) experiments











































Fraction of virus defective Fraction of cells infectible
Effect due to fraction of
cells infectible
Effect due to fraction of
virus defective
Fraction of virus defective 
and fraction of cells infectible
Fig. 4 Only a fraction of primary CD4+ T cells are susceptible to HIV infection regardless of viral titer. a Representative fusion and productive
infection (EGFP) data from 2 (of 4) healthy controls is shown. While viral fusion reaches a plateau at ~85–95 % of CD4+ T cells undergoing
fusion—consistent with expression of CXCR4—EGFP expression reaches a plateau at far lower levels (less than 15 % for all donors tested).
b Modeling of expected percentage of cells undergoing fusion or productive infection as a function of viral concentration. Different curves are
expected if a fraction of virus is defective, a fraction of cells are infectible, or both
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of the coreceptor used for entry or the percentage of lym-
phocytes than the virus can enter, only a fraction of un-
stimulated peripheral blood CD4+ cells can be productively
infected. It should be noted that the ‘defective viruses’ in
Fig. 4b refers to viruses that are incapable of producing
EGFP in the combination reporter virus assay. In vivo, ‘de-
fective interfering particles’ or DIPs with genomic deletions
have been reported to replicate at the expense of wild-type
virus; however these inhibitory effects occur at the level of
genome incorporation—downstream of LTR-driven EGFP
expression—and do not explain the plateauing of EGFP at
high levels of input virus observed here.
Double infection is disfavored in naïve CD4+ T cells and
occurs preferentially in the central memory CD4+ T cells
To determine whether double infection occurs stochas-
tically across all CD4+ T cell subsets or is favored in cer-
tain subsets compared to others, we compared the
contribution of naïve (TN, CCR7 + CD45RO-), central
memory (TCM, CCR7 + CD45RO+), and effector mem-
ory (TEM, CCR7-CD45RO+) subsets to singly (EGFP+ or
mCherry+) and doubly-infected (EGFP +mCherry+)
cells in 7 donors infected with 1:1 ratios of EGFP and
mCherry reporter viruses. Terminal effector (TTE,
CCR7-CD45RO-) CD4+ T cells were present at very low
frequencies and were not included in the analysis. No
significant differences were observed in subset distribu-
tion of cells infected by EGFP or mCherry viruses only
(TN: 33.88 ± 5.58 % EGFP+ v. 33.96 ± 5.81 % mCherry+,
p > 0.5; TCM: 52.76 ± 5.93 % v. 52.14 ± 6.17 %, p = 0.45;
TEM: 13.36 ± 2.84 v. 13.91 ± 2.99 %, p = 0.27, Fig. 5a). In
contrast, we observed that TN CD4+ T cells comprised a
significantly lower percentage of doubly infected cells
compared to singly infected cells (33.88 ± 5.58 % EGFP+
cells v. 27.30 ± 4.71 % EGFP +mCherry + cells, p =
0.009), whereas TCM were over-represented among
doubly infected cells (52.76 ± 5.93 % EGFP+ cells v.
57.14 ± 5.56 % EGFP +mCherry + cells, p = 0.015). TEM
cells were enriched among double positive cells but did
not reach statistical significance after corrections for
multiple comparisons (13.36 ± 2.84 v. 15.56 ± 2.47 %, p =
0.075). These data demonstrate that although double in-
fection occurs less frequently than single infection in all
subsets, double infection occurs less frequently in naïve
cells compared to memory cells, resulting in a preferential
enrichment of memory cells–particularly TCM–among
doubly-infected cells (Fig. 5b).
SAMHD1 restricts viral replication in CD4+ T cells but is
not responsible for preferential double infection of
memory subsets
The greater representation of memory cells–and particu-
larly central memory cells–among doubly-infected cells
could be the result of either (1) memory cells being
more susceptible to double infection or (2) naïve cells
being refractory to double infection. We have previously
found that naïve CD4+ T cells are refractory to HIV in-
fection compared with memory cells, with a smaller per-
centage progressing to LTR-driven EGFP expression
following fusion [19, 25]. This was in part due to
SAMHD1-mediated restriction of HIV infection in naïve
cells, as knockdown of SAMHD1 via Vpx-containing
viral like particles (VLPs) resulted in an ~20-fold in-
crease in EGFP expression in the TN subset compared to
only 5–8–fold increases in TCM and TEM subsets [25].
We reasoned that if SAMHD1 restricted entry of a sin-
gle virus in TN cells to a greater extent than in TCM and
TEM cells, the likelihood of two viruses successfully
completing reverse transcription, integration, and gene
expression would be multiplicatively more rare in TN
cells and could drive the observed changes in subset dis-
tribution. To test this hypothesis, we infected cells with
1:1 ratios of EGFP and mCherry reporter viruses in the
presence or absence of 1 mM dNs, which bypasses the
SAMHD1-mediated reduction of intracellular nucleotide
pools and facilitates viral reverse transcription [26, 27].
Treatment with exogenous dNs increased the total infec-
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Fig. 5 Central memory and effector memory cells constitute a larger percentage of doubly infected cells compared to singly infected cells.
a The frequencies of naïve (TN), central memory (TCM) and effector memory (TEM) cells within EGFP+/mCherry- (EGFP+), EGFP-/mCherry + (mC+),
and EGFP +mCherry + (EGFP +mC+) populations. Data are independent experiments in 7 healthy controls. b Contribution of TN, TCM, and TEM to
singly and doubly infected CD4+ T cells
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infected cells of the TN phenotype (p = 0.002 and p =
0.03, respectively, Fig. 6a), consistent with our previous
finding that SAMHD1 was a more potent restrictor of
HIV infection in TN cells than in TCM or TEM cells.
However, even in the presence of exogenous dNs, TN
cells were under-represented among doubly infected
cells compared to singly infected cells (p = 0.006, Fig. 6b).
Since SAMHD1 has recently been described to have
anti-HIV activity that is independent of its action in
regulating intracellular nucleotide pools [28], we also
tested the susceptibility of cells from a patient with the
homozygous mutation c.1411-2A > G in the samhd1
gene to infection with HIV. This mutation occurs in the
splice acceptor site of intron 12 of SAMHD1, leading to
the skipping of exon 13, an in-frame 31 amino acid dele-
tion, and the nearly complete absence of SAMHD1 pro-
tein by Western blot analysis [18]. Consistent with the
results of the exogenous dN experiments, cells from the
TN subset were represented at reduced frequencies
among doubly infected cells compared with singly in-
fected cells in this patient (Fig. 6c). Together, these data
indicate that while SAMHD1 restricts HIV infection in
CD4+ T cells—particular the TN subset—it is not re-
sponsible for the preferential inhibition of double infec-
tion in naïve T cells that results in the skewed
distribution of doubly-infected cells towards memory
subsets, particularly TCM cells.
Discussion
In this study, we investigated double infection of primary
CD4+ T cells using combination reporter viruses that
measure viral fusion and LTR-driven EGFP or mCherry
expression. In agreement with previous studies, double
infection of CD4+ T cells occurred more frequently than
expected. Several explanations for enhanced double in-
fection have been proposed, including (i) a fraction of
uninfectable target cells [17], (ii) variation in cellular
susceptibility to HIV [17], and (iii) suboptimal proviral
expression rescued by a second provirus via Tat expres-
sion in trans [15]. Whereas the experiments performed
in this study demonstrate the presence of uninfectable
target cells and the differential susceptibility of CD4+ T
cell subsets to HIV, no evidence for activation of silent
proviruses in trans was observed. Intriguingly, double in-
fection did not occur stochastically across all CD4+ T
cells maturation subsets but rather occurred preferen-
tially in central memory (TCM) cells. As SAMHD1 re-
stricts viral infection to a greater extent in naïve CD4+
T cells compared with memory cells [25], we speculated
that it could further reduce double infection of TN cells
and drive the observed subset differences between single
and double infection. However, preferential double infec-
tion of TCM cells was maintained even after bypassing
SAMHD1-mediated restriction of intracellular nucleo-
tide pools with exogenous nucleotides or in a patient
with the homozygous mutation c.1411-2A > G in the
samhd1 gene, suggesting other, currently unknown, fac-
tors influence preferential double infection of TCM cells.
From an experimental perspective, the titration experi-
ments performed with the combination reporter viruses
not only demonstrate that a single reporter virus is suffi-
cient for fusion and EGFP signals, but also provide
insight into the use of multiplicity of infection (MOI) in
normalizing for viral input and into the effect of spino-
culation on viral infection. MOI, as originally defined by
Max Delbrück in studies of T4 bacteriophage in the
1930s, referred to the ratio of infectious virions to host
cells using a plaque counting assay. As CD4+ T cells
grow in suspension, it is not possible to ‘count’ the num-
ber of replication competent viral foci in culture. The
most accurate method for calculating HIV titers is a lim-
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Fig. 6 SAMHD1-mediated restriction of HIV infection in naïve CD4+ T cells does not account for the differential distribution of naïve
(TN), central memory (TCM), and effector memory (TEM) subsets among singly (EGFP+ or mC+) and doubly infected (EGFP+ mC+) cells.
a Bypassing SAMHD1-mediated regulation of intracellular nucleotide pools via addition of exogenous dNs increased the representation of
naïve CD4+ cells in singly and doubly infected cell populations, indicating that SAMHD1 restricts HIV-1 infection to a greater extent in
naïve cells compared to memory cells. b Addition of exogenous dNs did not eliminate the under-representation of naïve T cells among
doubly infected cells compared to singly infected cells (p = 0.002). c A patient with sequence-confirmed mutations in samhd1 also demonstrated
increased contribution of TCM cells and decreased contribution of TN cells to the doubly infected cell population
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the viral concentration required to infect 50 % of the
wells, or TCID50. As this assay is laborious, surrogate
methods for determining titers have been developed that
rely upon detection of infected cells by reporter gene ex-
pression, integrated DNA, or even total DNA and using
these assays to calculate MOI. If all viruses were infec-
tious and all cells universally susceptible to infection,
these surrogates could be used interchangeably and
would provide accurate assessment of viral titers. How-
ever, for HIV this is clearly not the case and the above
surrogates provide increasingly inaccurate measures of
productive infection. Intuitively, the earlier in the viral life
cycle the surrogate measurement is taken, the higher the
proportion of cells that will appear infected and the less
accurately these assays will predict true, replication-
competent viral titers. For instance, our titration data
demonstrate that measuring viral infectivity using an early
life-cycle indicator (CCF2 dye cleavage) results in ~120-
fold higher MOIs than a late life-cycle indicator (LTR-
driven EGFP expression). In part, these discrepancies are
likely a result of defective viral particles: based on p24
concentrations and an estimate of roughly 5000 Gag
molecules per virus [29], the number of potential particles
is ~1,300-fold higher than the fusion-competent particles
and ~160,000-fold higher than the particles capable of giv-
ing rise to integration and LTR-driven EGFP expression.
These values are consistent with ratios of noninfectious or
inert virus particles per infectious units (P/IU) of 102–107
for HIV (recently reviewed by Klasse [30]). In addition,
these discrepancies between fusion and EGFP measure-
ments likely reflect heterogeneity in cellular susceptibility
to infection: more cells are susceptible to fusion with HIV
than are permissive to integration and LTR-driven EGFP
expression and, presumably, still fewer cells are fully sus-
ceptible to HIV replication. Surrogates for measuring HIV
titers are inherently imperfect, but our data indicate that
assays measuring late HIV life cycle stages will be more
accurate than those measuring early stages. These consid-
erations may be useful for the planning and interpretation
of experiments relying on normalizing viruses by MOI.
Spinoculation, the experimental technique of centri-
fuging cells in the presence of virus, has been demon-
strated to dramatically increase infection rates of target
cells [31]. Underscoring the profound effect of spinocu-
lation on HIV infection, MOIs for fusion and EGFP
were ~60–fold and 15–fold higher in the spinoculation
conditions, respectively. In other words, spinoculation
had an effect on viral infectivity equivalent to adding
between 15- and 60-fold more virus to the cells. Exactly
how spinoculation acts to promote viral infection re-
mains unclear, although recent reports suggest that it
may disrupt the cortical actin barrier and facilitate viral
entry into cells [32]. Our findings suggest that the pri-
mary effect of spinoculation occurs upstream of the
readout of the fusion assay; however, the precise re-
quirements for bla-Vpr–mediated CCF2 cleavage re-
main unknown. For instance, migration of the virus
through the cortical actin barrier, dissociation of the
p17 matrix shell of the virion, and perhaps additional
intracellular steps may be required to allow bla-Vpr to
interact with the CCF2 substrate, making ‘fusion assay’
a slight misnomer. Additionally, we observed that spi-
noculation improved the ‘fusion’ assay readout to a
greater extent than EGFP expression—60-fold and 15-
fold compared to no spinoculation, respectively—sug-
gesting that spinoculation may actually reduce the
efficiency of viral life cycle events between the stages of
CCF2 dye conversion and LTR-driven EGFP expression.
Further investigation into how spinoculation improves
infectivity of primary cells will be of considerable value
in understanding barriers to HIV infection and improv-
ing ex vivo transduction techniques.
From a biological perspective, the results from our
study suggest that the observed enhanced double infec-
tion rates in primary CD4+ T cells are primarily a result
of only a fraction of cells that can be infected by HIV-1
regardless of titer. Within this susceptible population,
single and double infection could be following the ex-
pected Poisson distribution but the large proportion of
cells resistant to the virus gives the appearance of en-
hanced double infection in the total CD4+ T cell popula-
tion. Additionally, we also observed that naïve CD4+ T
cells were more refractory to HIV infection following fu-
sion than memory subsets, in agreement with our previ-
ous findings [19]. Presciently, in their initial report [17],
Dang and colleagues proposed that non-random en-
hancement of double infection could be a consequence
of cells resistant to HIV infection or due to heterogen-
eity of primary CD4+ T cell populations, hypotheses that
have become testable and confirmed here via the devel-
opment of the combination reporter virus assay that
monitors multiple stages of the viral life cycle.
In contrast, we did not observe evidence for rescue of
proviral insufficiency by the production of Tat in trans by
a second provirus, as has been reported by Brégnard and
colleagues [15]. In agreement with Brégnard, we and
others have previously demonstrated that HIV can be-
come directly silenced following infection events as evi-
denced by enhancement of frequency of EGFP(+) cells
following stimulation with anti-CD3/CD28, SAHA, or
TNF-α. However, we found no evidence of enhanced
EGFP expression in cells infected with a constant level of
EGFP viruses and increasing concentrations of mCherry
viruses, suggesting that infection with a second provirus
did not reactivate silenced promoters via production of
Tat in trans. However, our experimental system differs
from that used by Brégnard in key ways that likely account
for these discrepant findings. First, in several experiments
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Brégnard and colleagues provided Tat in trans via trans-
fection rather than infection, which would likely result in
different levels of Tat protein expression than native infec-
tion. Second, the most definitive experiments demonstrat-
ing rescue by Tat in trans were performed using HeLa or
HPB-ALL cells, which are both immortalized cell lines
that may differ from primary CD4+ T cells in significant
ways such as the availability of transcription factors for
the LTR promoter. Indeed, we predict that the cells under-
going immediate silencing following infection have cellu-
lar conditions unfavorable to viral replication—such as
insufficient nuclear NF-κB to drive transcription—and
that a second provirus entering into these cells would en-
counter the same unfavorable environment and also
undergo silencing following integration.
The experimental system used in this manuscript de-
scribes near-simultaneous infection of cells by two dis-
tinct viruses, or co-infection. Another potential route of
double infection in vivo is sequential infection where a
cell becomes infected with a virus and is subsequently
infected with a second virus at a later time. Which of
these routes predominates in patients is not clear; how-
ever, HIV has mechanisms to prevent sequential infec-
tion at the cellular level, including Nef-mediated CD4+
down-regulation. Indeed, in our assay, unstimulated cells
infected with a virus encoding nef have undetectable
levels of CD4 by 3 days after infection [19] and become
resistant to infection with a second virus. In activated
cells, where reverse transcription and integration occur
more efficiently, CD4 is likely down-regulated even more
rapidly. We believe that in the context of an active HIV
infection, particularly in lymphoid tissues such as lymph
node or spleen, the level of viral replication in vivo could
conceivably lead to cells being exposed to multiple vi-
ruses in a short time frame similar to the experimental
conditions used here. Studies of splenocytes from HIV-
infected patients have indeed demonstrated the presence
of cells infected with multiple viruses [33, 34], suggesting
that cells were exposed to multiple viruses in this cell-
rich environment either simultaneously or in rapid suc-
cession, prior to down-regulation of CD4.
Finally, the finding that double infection did not occur
stochastically across all subsets but rather was favored in
central memory (TCM) cells further confirms the hetero-
geneity of CD4+ T cells with respect to HIV infection. As
TCM cells are among the longest-lived subsets of CD4+ T
cells and are a primary contributor to the latent reservoir
in patients treated with antiretroviral therapy [35], their
preferential double infection implies that these cells may
represent an archived population of cells with multiple
proviruses that can drive ongoing recombination in vivo,
with significant implications for the reshuffling of viral ge-
nomes during periods of treatment interruption or inter-
mittent viremia.
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